These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. Pawlak K; Pawlak D; Mysliwiec M Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733 [TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH). Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753 [TBL] [Abstract][Full Text] [Related]
11. [Conservative therapy for chronic renal failure]. Filipenko PS; Moiseenkova NN Klin Med (Mosk); 2004; 82(12):9-15. PubMed ID: 15732711 [No Abstract] [Full Text] [Related]
12. Adrenergic overdrive: a 'not-so-sympathetic' risk factor in renal failure patients. Jordan J; Grassi G J Hypertens; 2007 Jun; 25(6):1197-9. PubMed ID: 17563531 [No Abstract] [Full Text] [Related]